Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation. [PDF]
Thompson KM +2 more
europepmc +1 more source
Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial. [PDF]
Snider CJ +11 more
europepmc +1 more source
Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV). [PDF]
Badizadegan ND +6 more
europepmc +1 more source
Post-vaccination campaign evaluation of systemic and mucosal immunity of trivalent oral poliovirus vaccine in Karachi, Pakistan (2020-2021): a cross-sectional study. [PDF]
Saleem AF +9 more
europepmc +1 more source
Quantitative RT-PCR Assays for Quantification of Undesirable Mutants in the Novel Type 2 Oral Poliovirus Vaccine. [PDF]
Manukyan H +7 more
europepmc +1 more source
Immunogenicity and Safety of Sabin Strain Inactivated Poliovirus Vaccine Booster Dose Administered Separately or Concomitantly with Inactivated Hepatitis A Vaccine or Measles-Mumps-Rubella Combined Attenuated Live Vaccine: An Open-Labelled, Randomized, Controlled, Phase 4 Clinical Trial. [PDF]
Hu J +10 more
europepmc +1 more source
Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization. [PDF]
Thompson KM +4 more
europepmc +1 more source
Inactivated Poliovirus Vaccine: Recent Developments and the Tortuous Path to Global Acceptance. [PDF]
Sutter RW +4 more
europepmc +1 more source
Long-Term Persistence of Anti-Poliovirus Antibody Titers After Two-Dose Booster Immunization with Conventional Inactivated Poliovirus Vaccine Among Japanese Adults: 10-Year Observational Study. [PDF]
Fukushima S +4 more
europepmc +1 more source

